74 related articles for article (PubMed ID: 28789597)
1. MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cells.
Li X; Grigalavicius M; Li Y; Li X; Zhong Y; Huang R; Yu D; Berge V; Goscinski MA; Kvalheim G; Nesland JM; Suo Z
Tumour Biol; 2017 Aug; 39(8):1010428317713671. PubMed ID: 28789597
[TBL] [Abstract][Full Text] [Related]
2. MtDNA depleted PC3 cells exhibit Warburg effect and cancer stem cell features.
Li X; Zhong Y; Lu J; Axcrona K; Eide L; Syljuåsen RG; Peng Q; Wang J; Zhang H; Goscinski MA; Kvalheim G; Nesland JM; Suo Z
Oncotarget; 2016 Jun; 7(26):40297-40313. PubMed ID: 27248169
[TBL] [Abstract][Full Text] [Related]
3. Blocking mtDNA replication upregulates the expression of stemness-related genes in prostate cancer cell lines.
Liu Y; Wu X; Li X; Kvalheim G; Axcrona U; Axcrona K; Suo Z
Ultrastruct Pathol; 2013 Aug; 37(4):258-66. PubMed ID: 23634795
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA depletion reduces PARP-1 levels and promotes progression of the neoplastic phenotype in prostate carcinoma.
Moro L; Arbini AA; Marra E; Greco M
Cell Oncol; 2008; 30(4):307-22. PubMed ID: 18607066
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer cell lines under hypoxia exhibit greater stem-like properties.
Ma Y; Liang D; Liu J; Axcrona K; Kvalheim G; Stokke T; Nesland JM; Suo Z
PLoS One; 2011; 6(12):e29170. PubMed ID: 22216200
[TBL] [Abstract][Full Text] [Related]
6. Poly r(C) binding protein-1 is central to maintenance of cancer stem cells in prostate cancer cells.
Chen Q; Cai ZK; Chen YB; Gu M; Zheng DC; Zhou J; Wang Z
Cell Physiol Biochem; 2015; 35(3):1052-61. PubMed ID: 25661993
[TBL] [Abstract][Full Text] [Related]
7. Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line.
Chen Y; Zhao J; Luo Y; Wang Y; Jiang Y
Oncol Rep; 2016 Nov; 36(5):2587-2600. PubMed ID: 27573045
[TBL] [Abstract][Full Text] [Related]
8. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells.
Patrawala L; Calhoun-Davis T; Schneider-Broussard R; Tang DG
Cancer Res; 2007 Jul; 67(14):6796-805. PubMed ID: 17638891
[TBL] [Abstract][Full Text] [Related]
9. Dietary Flavonoids Luteolin and Quercetin Suppressed Cancer Stem Cell Properties and Metastatic Potential of Isolated Prostate Cancer Cells.
Tsai PH; Cheng CH; Lin CY; Huang YT; Lee LT; Kandaswami CC; Lin YC; Lee KP; Hung CC; Hwang JJ; Ke FC; Chang GD; Lee MT
Anticancer Res; 2016 Dec; 36(12):6367-6380. PubMed ID: 27919958
[TBL] [Abstract][Full Text] [Related]
10. Methylation of the CD44 metastasis suppressor gene in human prostate cancer.
Lou W; Krill D; Dhir R; Becich MJ; Dong JT; Frierson HF; Isaacs WB; Isaacs JT; Gao AC
Cancer Res; 1999 May; 59(10):2329-31. PubMed ID: 10344738
[TBL] [Abstract][Full Text] [Related]
11. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
Rybak AP; He L; Kapoor A; Cutz JC; Tang D
Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
[TBL] [Abstract][Full Text] [Related]
12. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
13. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of cancer stem cells in human prostate cancer cells.
Lee EK; Cho H; Kim CW
Biochem Biophys Res Commun; 2011 Aug; 412(2):279-85. PubMed ID: 21820414
[TBL] [Abstract][Full Text] [Related]
15. Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
Palapattu GS; Wu C; Silvers CR; Martin HB; Williams K; Salamone L; Bushnell T; Huang LS; Yang Q; Huang J
Prostate; 2009 May; 69(7):787-98. PubMed ID: 19189306
[TBL] [Abstract][Full Text] [Related]
16. Method of detecting new cancer stem cell-like enrichment in development front assay (DFA).
Saha A; Shree Padhi S; Roy S; Banerjee B
J Stem Cells; 2014; 9(4):235-42. PubMed ID: 25942339
[TBL] [Abstract][Full Text] [Related]
17. The natural flavonoid apigenin sensitizes human CD44
Erdogan S; Turkekul K; Serttas R; Erdogan Z
Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
[TBL] [Abstract][Full Text] [Related]
18. CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance.
Ni J; Cozzi PJ; Hao JL; Beretov J; Chang L; Duan W; Shigdar S; Delprado WJ; Graham PH; Bucci J; Kearsley JH; Li Y
Prostate; 2014 May; 74(6):602-17. PubMed ID: 24615685
[TBL] [Abstract][Full Text] [Related]
19. CD44(high)CD24(low) molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma.
Ghuwalewala S; Ghatak D; Das P; Dey S; Sarkar S; Alam N; Panda CK; Roychoudhury S
Stem Cell Res; 2016 Mar; 16(2):405-17. PubMed ID: 26926234
[TBL] [Abstract][Full Text] [Related]
20. Tunicamycin-induced endoplasmic reticulum stress reduces in vitro subpopulation and invasion of CD44+/CD24- phenotype breast cancer stem cells.
Nami B; Donmez H; Kocak N
Exp Toxicol Pathol; 2016 Aug; 68(7):419-26. PubMed ID: 27350212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
